Testosterone Science

Finasteride and Dutasteride - BPH, Hair, and the Sexual Trade-offs

They shrink the prostate and regrow hair by cutting DHT - and that is exactly where the sexual side effects come from.

5-Alpha-Reductase InhibitorFDA Approved (Finasteride 5mg 1992, 1mg 1997; Dutasteride 2001)

Tamsulosin and the BPH-Drug Sexual Side Effect

Fast relief for BPH symptoms - at the cost of 'dry orgasm' for many men on tamsulosin.

Alpha-1 Adrenergic AntagonistFDA Approved (Tamsulosin 1997)

AbbVie AndroGel, Testim, Fortesta, Vogelxo, Axiron

The product that built the 'Low T' market, and its transference warning.

Transdermal AndrogenFDA Approved (AndroGel 2000)

Chemical Castration in Prostate Cancer - The Opposite of TRT

The therapeutic mirror image of TRT: deliberately driving testosterone to castrate levels.

Androgen Suppression TherapyFDA Approved (GnRH agonists/antagonists; e.g., leuprolide 1985, degarelix 2008)

Complete & Partial AIS, the Androgen-Receptor Defect and the 46,XY Phenotype Spectrum

Plenty of testosterone, but the receptor cannot hear it.

X-Linked Androgen-Receptor Disorder / DSDNot applicable (genetic condition)

Prevalence, Fertility & Cancer Implications, and the Timing of Orchidopexy

The most common male genital birth anomaly, and a window that closes.

Developmental Anomaly / Pediatric SurgeryNot applicable (condition; orchidopexy is standard surgical care)

Pfizer / generic, the injectable workhorse

The most-prescribed testosterone in the US, cheap, effective, and swingy.

Injectable Androgen EsterFDA Approved (Depo-Testosterone)

Dihydrotestosterone, External-Genitalia Masculinization & 5-Alpha-Reductase-2 Deficiency (the Guevedoces)

The experiment of nature that separated testosterone from its more potent metabolite.

Developmental Endocrinology / Enzyme DefectNot applicable (developmental biology / inherited condition)

Dihydrotestosterone, the Conversion Enzyme, and the Drugs That Block It

The more potent androgen most men have never heard of, and the pill that suppresses it.

Androgen Metabolism PathwayFinasteride FDA Approved (1992 BPH, 1997 hair loss)

Why Morning Matters, and the Home Test Kit Timing Problem

The same man can be 'hypogonadal' at 4 PM and normal at 8 AM, timing is the test.

Pre-Analytical Testing FactorN/A (testing methodology)

Erectile dysfunction as a sentinel event, endothelial dysfunction, and the Princeton Consensus

The penile artery is narrow. It clogs first - often years before the heart announces itself.

Vascular Sentinel MarkerNot an FDA product (a clinical risk marker; ED treatments are separately regulated)

Gonadotropin-Releasing Hormone and Hypothalamic Pulsatility

The hypothalamic clock that times the whole axis.

Hypothalamic Releasing HormoneEndogenous hormone (analogs are separately regulated)

The Bidirectional Link Between Metabolic Health and Androgens

The most common reversible cause of low testosterone in men today.

Metabolic Driver of HypogonadismNot a product (a metabolic relationship)

47,XXY, Chromosomal Origin, Phenotype Across Life, and the Under-Diagnosis Problem

The commonest sex-chromosome disorder in men, and the most missed.

Sex-Chromosome AneuploidyNot applicable (genetic condition; TRT is a treatment, not a cure)

Why how testosterone is measured changes the answer

Two men, same blood, different testosterone number, depending on the assay.

Laboratory ScienceNot applicable (assay methodology)

Luteinizing Hormone and Follicle-Stimulating Hormone

The two pituitary signals that run the testes.

Pituitary GonadotropinsEndogenous hormones (not a product)

Using the Gonadotropins to Separate Primary (Testicular) from Secondary (Central) Hypogonadism

Two cheap labs that change everything. LH and FSH tell you WHERE the axis is broken, and therefore what to do.

Pituitary GonadotropinsN/A (diagnostic analytes); hCG/recombinant gonadotropins are FDA-approved therapeutics

Kisspeptin, the GnRH Reawakening, and the Timeline of Male Sexual Maturation

The switch that wakes the reproductive axis, and the staging system that tracks it.

Developmental EndocrinologyNot applicable (developmental physiology)

David & Laqueur's Naming, Butenandt & Ruzicka's Synthesis, and the Shared 1939 Nobel Prize, the Granular Account

1935: four months from first crystals to two independent syntheses, the molecule got a name and a factory route in a single year.

Foundational Scientific DiscoveryNot Applicable (1935 chemical discovery)

Male obesity-related secondary hypogonadism (weight loss as treatment)

The low-T cause where the treatment is the scale, not the syringe.

Functional Secondary HypogonadismNot a product; weight loss is the evidence-based intervention

Cochrane Reviews and Pivotal RCTs of Sildenafil, Tadalafil, Vardenafil, Avanafil for ED

The deepest randomized evidence base in all of men's sexual medicine.

Evidence-Synthesis Dossier (Cochrane + RCTs)FDA-approved drug class backed by Cochrane-level evidence

Central vs Peripheral Precocity, Causes, and GnRH-Analogue Treatment

Too soon, too fast, and why the cause changes everything in boys.

Developmental Endocrinology / PediatricGnRH analogues FDA-approved for central precocious puberty

Testicular Failure vs Central (HPG Axis) Failure, The LH/FSH Distinction

The single measurement that tells you where the problem is, and whether it can be reversed.

Clinical Diagnostic FrameworkN/A (diagnostic category)

Prolactin's Suppression of the Gonadal Axis

A hidden, treatable cause of low testosterone and low libido.

Pituitary Hormone / Axis DisruptorEndogenous hormone (a measured lab value)

Prostatectomy, Radiation, and ADT Effects on Erections and Ejaculation

Curing the cancer and preserving sexual function are different goals - and patients deserve honest numbers.

Treatment-Related Sexual DysfunctionNot applicable (treatment outcomes)

CDC Hormone Standardization (HoSt) and Harmonized Testosterone Ranges

Making one lab's testosterone number mean the same as another's.

Laboratory Standardization ProgramNot a product (a laboratory standardization initiative)

SRY, the Testis-Determining Cascade, Wolffian Ducts & the Masculinization Programming Window

How a genetically male embryo is built, and why timing is everything.

Developmental EndocrinologyNot applicable (developmental biology)

Oral Sildenafil in the Treatment of Erectile Dysfunction (Goldstein et al., NEJM 1998)

The trial that launched the oral-ED era and made Viagra a household name.

Pivotal Registration RCT (Trial Dossier)Pivotal trial supporting Viagra approval (1998)

Androgens, Satellite Cells, and Dose-Dependent Lean Mass

The dose-dependent effect that fuels both medicine and misuse.

Anabolic MechanismNot a product (a physiological mechanism)

Polycythemia / Erythrocytosis, The Primary Physiological Risk of TRT

The number that should be checked more than any other on TRT, and often isn't.

Hematologic Effect of AndrogensN/A (physiological mechanism)

Master Reference, Biochemistry, the HPG Axis, Measurement, Decline, and the TRAVERSE Era

The hormone the entire marketplace is built on, and the single entry that anchors everything else in this library.

Endogenous Androgen / Steroid HormoneFDA Approved (testosterone products approved only for hypogonadism caused by an underlying medical condition; 2015 labeling action; February 2025 cardiovascular black-box removal)

FDA Labeling Restriction and the End of the AndroGel 'Low T' Campaign

The day the regulator told the industry to stop selling testosterone as an antidote to aging.

Regulatory ActionFDA Safety Communication & Label Change (March 2015)

How Testosterone and DHT Actually Signal in Cells

The single molecular switch every androgen has to flip.

Nuclear Hormone ReceptorNot a product (the molecular target of androgens)

Hypothalamic-Pituitary-Gonadal Axis: GnRH Pulsatility, LH/FSH, and Negative Feedback

The master control loop. Every hormone, drug, and lifestyle factor in this library acts somewhere on this circuit.

Integrated Endocrine SystemN/A (physiological system, not a product)

Butenandt, Ruzicka & the 1935 Synthesis (Nobel 1939)

1935: the molecule behind a century of hormone science.

Scientific Discovery / HistoryNot Applicable (1935 chemical discovery)

Every FDA-approved testosterone product, mapped

One molecule, a dozen delivery systems, each with a different release curve.

Pharmacology ReferenceMultiple FDA-approved products

Testosterone Replacement and Vascular Events in Hypogonadal Men, The Cardiovascular Safety RCT

The largest testosterone safety trial ever run, and the reason the cardiovascular black box is gone.

Landmark Cardiovascular Safety RCTBasis for Feb 2025 FDA label change

Testosterone Replacement Therapy for Assessment of Long-term Vascular Events and Efficacy Response in Hypogonadal Men (Lincoff et al., NEJM 2023)

The trial that answered the FDA's 2015 cardiovascular safety question for TRT.

Cardiovascular-Safety RCT (Trial Dossier)FDA-mandated post-marketing safety trial (results 2023)

Cardiovascular Safety RCT, the Fracture Signal, and What It Did and Did Not Show

Reassuring on the heart, not a green light for 'optimization', and it raised new questions.

Pivotal Safety RCTInformed the February 2025 FDA removal of the testosterone cardiovascular boxed warning; indication remains restricted to medically-caused hypogonadism

Complete Comparison, IM, SubQ, Gel, Pellets, Patch, Oral, Buccal, and Nasal

Every route delivers testosterone, they differ in kinetics, monitoring, transfer risk, and how easily a dose can be corrected.

Testosterone Replacement FormulationsMultiple FDA-approved formulations; routes differ in label and warnings

BLSA / Harman 2001 (~1%/yr), and the Aging-vs-Comorbidity Debate

The hormone falls with age, but how much is aging, and how much is the diseases that come with it?

Epidemiologic / Physiologic DataNot an FDA-regulated entity (data topic); age-related decline is not an approved treatment indication

Lasting HPG suppression after anabolic-androgenic steroid use

The crash after the cycle, and why it can outlast the drugs by years.

Drug-Induced Secondary HypogonadismAAS are controlled substances; off-label recovery agents used

The transdermal patch that gels displaced

Steady levels, but a high rate of skin irritation.

Transdermal PatchFDA Approved (Androderm)

Tissue Distribution, the Obesity Connection, and the Genetics of Aromatase Excess and Deficiency

The enzyme that converts testosterone into estradiol, and the reason fat tissue quietly reshapes a man's hormones.

Steroidogenic Enzyme (CYP450)N/A (endogenous enzyme); aromatase inhibitors FDA-approved for breast cancer

Endo, the long-acting injectable with a REMS

Injected only every 10 weeks, but under a safety program.

Long-Acting InjectableFDA Approved (Aveed 2014, REMS)

Arnold Adolph Berthold's Testes-Transplantation in Cockerels, The Founding Experiment of Endocrinology

1849: the experiment that proved glands secrete chemical messengers into the blood.

Foundational Scientific ExperimentNot Applicable (1849 experiment)

Benign Prostatic Hyperplasia and the Androgen-Estrogen Relationship

BPH is driven by DHT and the shifting androgen-to-estrogen ratio of aging - not by high testosterone.

Hormone-Urology ConceptNot applicable (condition/concept)

The Vermeulen Equation, Equilibrium Dialysis, and Direct Assays

How labs estimate the fraction of testosterone that can actually act, and why the method matters.

Measurement MethodologyNot applicable (laboratory methodology)

Court Eunuchs, the Ottoman & Byzantine Castrato Bureaucracies, and the Castrati Singers, The Original Testes-to-Virility Experiment

Before hormones had a name, removing the testes proved they made a man a man.

Historical / Pre-Scientific ObservationNot Applicable (historical practice)

Low testosterone in CKD/dialysis - the prolactin and uremic-toxin contribution

Failing kidneys mean failing libido - uremia disrupts the axis and lets prolactin climb.

Systemic-Disease HypogonadismNot an FDA product (manifestation of systemic disease)

Cirrhosis, ethanol gonadotoxicity, SHBG and the estrogen/androgen ratio shift

The classic exam-room triad: gynecomastia, spider angiomata, testicular atrophy - the liver shifting the hormone balance toward estrogen.

Systemic-Disease HypogonadismNot an FDA product (manifestation of systemic disease)

Regulatory and Quality Differences Between Compounded and Approved Products

Why two testosterone vials are not the same in the eyes of the FDA.

Regulatory / Quality DistinctionFDA-approved products vs non-FDA-approved compounded preparations

How the Stress Axis Suppresses the Sex Axis: Cushing's, Adrenal Disease, and Glucocorticoid Effects

The stress axis and the sex axis are wired against each other. Chronic cortisol is a brake on male reproductive function.

Adrenal Glucocorticoid AxisN/A (endogenous hormone / axis)

Constitutional Delay vs Hypogonadotropic vs Hypergonadotropic Causes & Evaluation

Late bloomer, broken signal, or failing gonad? The fork that decides the workup.

Developmental Endocrinology / Diagnostic WorkupNot applicable (clinical condition; some therapies are off-label/approved drugs)

Dihydrotestosterone, the Potent Androgen Behind Hair Loss, Prostate Growth, and Skin Effects

The downstream androgen that does much of testosterone's work in skin, hair, and prostate.

Androgen Metabolite / Enzyme Pathway5-alpha-reductase inhibitors FDA-approved for BPH (finasteride, dutasteride) and hair loss (finasteride; dutasteride is off-label for hair loss in the US), not for TRT management

Low testosterone with type 2 diabetes, insulin resistance and metabolic syndrome

Low testosterone and metabolic disease feed each other.

Functional Secondary HypogonadismNot a product; addressed via metabolic management +/- testosterone

5-Alpha-Reductase Physiology: Where DHT Matters vs Where Testosterone Acts Directly

The androgen amplifier. Testosterone does some jobs itself; for others it must first become DHT.

Potent Androgen MetaboliteN/A (endogenous metabolite); 5-ARIs (finasteride, dutasteride) are FDA-approved

SSRIs/SNRIs, 5-ARIs (finasteride/PFS), antipsychotics, antihypertensives, spironolactone, chemotherapy

Before you label it 'low T,' check the medicine cabinet. Several of the most common prescriptions in medicine cause sexual dysfunction directly.

Iatrogenic Sexual DysfunctionNot an FDA product (adverse-effect survey across multiple approved drug classes)

The GDR's Systematic, Documented State-Sponsored Doping Program, Oral-Turinabol and the Athletes Who Paid

A government that doped thousands of its own athletes, many minors, often without consent, and wrote it down.

Historical / State-Sponsored DopingNot Applicable (illicit state program; agents were prescription/controlled drugs)

European Male Ageing Study (Wu et al., NEJM 2010)

The cohort that defined late-onset hypogonadism with actual symptom-hormone thresholds.

Definitional Epidemiology Cohort (Trial Dossier)Observational multicenter cohort (not a drug study)

Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline (Bhasin et al., JCEM 2018)

The reference framework that turns testosterone evidence into prescribing discipline.

Evidence-Synthesis Guideline (Dossier)Professional society guideline synthesizing approved-therapy evidence

Why Men Need Estrogen, and What Aromatase Inhibitors Actually Do

Estrogen is not the enemy of male health, the marketplace's reflex to crush it is often the problem.

Estrogen / Aromatase PathwayAromatase inhibitors are not FDA-approved for routine TRT estradiol management (off-label)

Why Estrogen Is Essential to Male Libido, Bone, and Fat Regulation (Finkelstein 2013 NEJM)

Estrogen is not the enemy. In men it is the hormone that actually drives libido and protects bone, and crushing it does real harm.

Essential Male Sex SteroidN/A (endogenous hormone); aromatase inhibitors are FDA-approved for other indications

Gonadal Steroids and Body Composition, Strength, and Sexual Function in Men (Finkelstein et al., NEJM 2013)

The graded-deprivation trial that proved estradiol - not just testosterone - drives key male traits.

Dose-Response Mechanistic RCT (Trial Dossier)Investigator-initiated mechanistic RCT

Injectable, Transdermal, and Other Testosterone Regimens, and How Targets Differ from Hypogonadism TRT

Same molecules as TRT, different aim: titrate to a typical male range and to the masculinization the patient wants.

Dosing & Formulation ReferenceOff-label; products used are the same FDA-approved testosterone esters/gels labeled for male hypogonadism

How free testosterone is really measured, and mismeasured

The 'direct free T' your lab reports is often the least reliable number on the page.

Laboratory ScienceNot applicable (assay methodology)

The Three Numbers, the Active Fraction, and Why They Disagree

Why a 'normal' total can hide a low active level, and vice versa.

Hormone Measurement ConceptNot applicable (measurement concept)

Illness- and steroid-related suppression of the testosterone axis

Sickness and steroids both turn the testosterone dial down.

Functional Secondary HypogonadismNot a product; an effect of glucocorticoids and systemic illness

Chronic corticosteroids suppressing the gonadal axis (and bone)

Prednisone fixes the inflammation and quietly turns down the gonadal axis - and the bone that low testosterone was protecting.

Iatrogenic Secondary HypogonadismNot an FDA product (drug class adverse effect)

The Primary Physiological Safety Concern of Testosterone Therapy

Testosterone makes red blood cells, too many is the risk that hides in plain sight.

TRT Safety MonitoringHematocrit monitoring is standard of care on FDA-approved testosterone therapy

HFE iron overload depositing in the pituitary and testes (the reversible miss)

Rust in the pituitary, and one of the few low-T causes you can drain away.

Iron-Overload Secondary (and Primary) HypogonadismTreated with therapeutic phlebotomy (procedure) and chelation

From AIDS-wasting-era androgen deficiency to the modern ART context

In the wasting era, hypogonadism was rampant and testosterone was a wasting therapy. On modern ART, the picture is quieter but not gone.

Systemic-Disease HypogonadismNot an FDA product (testosterone HAS niche approval contexts; see notes)

Interpreting Total, Free, SHBG, LH/FSH, and Why Method and Timing Decide the Number

The single most useful page for a man who just got handed a lab printout.

Clinical Interpretation GuideNot applicable (interpretive guide)

Pituitary failure from trauma, surgery, radiation, apoplexy and Sheehan

When the master gland fails, testosterone is rarely the only thing lost.

Secondary Hypogonadism (Pituitary/Hypothalamic Failure)Managed with approved hormone replacement agents

The Seminiferous-Tubule Marker the Testosterone Conversation Forgets

Testosterone tells you about Leydig cells; inhibin B tells you about sperm.

Reproductive BiomarkerNot applicable (endogenous biomarker)

The Obesity-Hypogonadism Mechanism: How Metabolic Hormones Regulate Male Reproductive Function

Obesity is not just a risk factor for low testosterone, it is a hormonal mechanism. And it is substantially reversible.

Metabolic-Reproductive InterfaceN/A (endogenous hormones / physiological mechanism)

Congenital Hypogonadotropic Hypogonadism (GnRH neuron migration failure)

When the brain never learned to ask the testes to work.

Congenital Secondary HypogonadismNot an FDA product (clinical diagnosis; treated with approved agents)

47,XXY, the most common cause of primary hypogonadism in men

An extra X chromosome and the most common primary hypogonadism.

Primary (Hypergonadotropic) HypogonadismClinical/genetic diagnosis; managed with approved testosterone agents

The pre-analytic variables that distort a testosterone panel

Half of a 'low testosterone' diagnosis can be the conditions of the blood draw.

Laboratory ScienceNot applicable (lab interpretation)

EMAS Diagnostic Criteria, Prevalence, and the Physiology of the Aging HPG Axis

A real but uncommon and strictly defined syndrome, far rarer than the marketplace implies.

Clinical Syndrome (Age-Associated Androgen Deficiency)No FDA-approved indication for age-related decline alone; testosterone is approved only for hypogonadism due to an underlying medical condition (2015 labeling action)

What Testosterone Does and When, Expected Virilization, Time Course, and What It Cannot Reverse

Some changes are fast and reversible; others are slow and permanent. Honest counseling means naming both.

Clinical Effect TimelineOff-label use; effect timelines summarized in WPATH SOC-8 and Endocrine Society guidance

Gender-Affirming Testosterone for Transmasculine and Nonbinary People, Goals, Frameworks, and Models of Care

A clinically distinct, guideline-supported use of testosterone, masculinization toward a target male physiological range, not 'optimization.'

Gender-Affirming Hormone Therapy (Testosterone)Off-label (no FDA testosterone product is labeled for gender-affirming care; use is supported by major clinical guidelines)

The bidirectional relationship between MetS, low T, and the obesity-aromatase loop

Fat lowers testosterone; low testosterone adds fat. The chicken-and-egg loop the supplement industry sells as a one-way story.

Cardiometabolic HypogonadismNot an FDA product (clinical syndrome; testosterone not approved for metabolic syndrome)

Central Obesity, Insulin Resistance, and the Bidirectional Low-T Loop

Low testosterone and metabolic syndrome feed each other in a vicious circle.

Metabolic-Endocrine LinkNot applicable; TRT not approved to treat metabolic syndrome

The Postnatal HPG Activation & Testosterone Surge of the First Months of Life

A transient blast of testosterone in the cradle, then a decade of quiet.

Developmental EndocrinologyNot applicable (developmental physiology)

Massachusetts Male Aging Study (Feldman et al., Journal of Urology 1994)

The cohort that first quantified how common erectile dysfunction really is.

Foundational Epidemiology Cohort (Trial Dossier)Observational community cohort (not a drug study)

Acerus, the fertility-sparing option

The one testosterone that may not tank your sperm count.

Intranasal AndrogenFDA Approved (Natesto)

OPIAD - central HPG suppression in the chronic-pain population

Chronic opioids tell the brain to stop asking the testes to work. The pain clinic is full of secondary hypogonadism nobody screened for.

Iatrogenic Secondary HypogonadismNot an FDA product (drug class effect; no opioid is approved as an androgen-deficiency therapy)

Opioid-induced androgen deficiency, a large, under-recognized cause

The hidden hormonal cost of long-term opioids.

Drug-Induced Secondary HypogonadismNot a product; a recognized adverse effect of opioid therapy

Jatenzo and Kyzatrex, Modern Oral TRT and the PRIME / Mangoceuticals DTC Channel

The pill that finally avoided the liver, and traded that win for a blood-pressure warning.

Oral Testosterone (Undecanoate)Jatenzo FDA Approved 2019; Kyzatrex 2022

Hyperprolactinemia, the Prolactinoma Workup, and Dopamine-Agonist Treatment

The hormone that can shut down libido and the whole axis at once, and the one TRT clinics too often forget to measure.

Pituitary Hormone (Lactotroph)N/A (endogenous hormone); cabergoline/bromocriptine are FDA-approved

Hyperprolactinemia-driven secondary hypogonadism (dopamine-agonist treatable)

A small benign tumor that switches off the testosterone signal.

Secondary Hypogonadism (Pituitary Tumor)Dopamine agonists FDA approved for hyperprolactinemia

Prostate-Specific Antigen, Testosterone Therapy, and the Screening Debate

TRT does not exempt a man from prostate monitoring - it makes structured PSA follow-up part of the deal.

Monitoring ProtocolNot applicable (lab test / monitoring practice)

The Carrier Protein That Sets the Active Testosterone Fraction

The dial that decides how much of your testosterone is actually usable.

Binding GlobulinNot applicable (endogenous protein / lab value)

Sex Hormone-Binding Globulin, What Raises It, What Lowers It, and Why Free Testosterone Depends On It

The protein that decides how much of your testosterone is actually available.

Hormone Transport ProteinN/A (endogenous protein / lab measure)

Sex Hormone-Binding Globulin: The Variable That Quietly Rewrites Every Total-Testosterone Result

Before you trust a total-T number, you have to know the SHBG. It sets how much of that hormone is actually available.

Hepatic Transport GlycoproteinN/A (measured analyte, not a product)

The Arnold/Gold's Gym Generation and the Cultural Normalization of Anabolic Steroids

How a Venice Beach gym subculture made anabolic steroids aspirational, and how that legacy feeds today's online 'enhanced' physique market.

Historical / Cultural Normalization of SteroidsAnabolic steroids Schedule III controlled substances in the US (1990 Anabolic Steroid Control Act)

Testosterone for the Prevention of Type 2 Diabetes Mellitus (Wittert et al., Lancet Diabetes & Endocrinology 2021)

The trial showing testosterone plus lifestyle reduced type 2 diabetes incidence - with caveats.

Diabetes-Prevention RCT (Trial Dossier)Investigator-initiated RCT (prevention indication, not approved)

The One FDA-Approved GH-Releasing Peptide (HIV Lipodystrophy)

Proof a GH-releasing peptide can clear the FDA, for one specific indication.

GHRH Analog (FDA-Approved)FDA Approved 2010 (Egrifta); F8/weekly formulation (Egrifta WR) approved later

Androgens, Estradiol, and Male Skeletal Health

Why estradiol, not just testosterone, protects men's bones.

Skeletal Endpoint of Androgen StatusNot a product (a physiological outcome)

The Full Picture - Beyond TRAVERSE and the ED-as-Sentinel Link

Testosterone's heart story is nuanced - and erectile dysfunction is often the first warning the heart is in trouble.

Cardiovascular-Hormone ConceptNot applicable (concept); FDA removed CV black-box language Feb 2025

The Saturation Model and the Overturned 70-Year Fear

The dogma that testosterone 'feeds' prostate cancer was built on a single patient.

Hormone-Oncology ConceptNot applicable (clinical concept, not a product)

Comparing the Two Workhorse Injectable Esters

Nearly interchangeable in practice, the differences are smaller than the marketplace implies.

Injectable Testosterone EstersBoth FDA-approved injectable testosterone esters

Cypionate vs Enanthate vs Propionate, How the Ester Sets the Half-Life

Same hormone, different chemical tail, and the tail decides how often you inject.

Injectable Testosterone EstersCypionate & Enanthate FDA Approved; Propionate limited US availability

Hepatic Conjugation, 5-Alpha Reduction, Aromatization, and Excretion

What the body does to testosterone, and why oral testosterone fought the first-pass effect for decades.

Pharmacology / MetabolismNot applicable (endogenous metabolism)

Why Testosterone Was Withheld From Hypogonadal Men for Decades

Half a century of men denied treatment - on the strength of a single 1941 patient.

Medical HistoryNot applicable (historical narrative)

Why men need the LC-MS/MS estradiol test, not the standard one

Standard estradiol assays were built for women's high levels, they misread men's.

Laboratory ScienceNot applicable (assay methodology)

Where Replacement Ends and Anabolic Steroid Use Begins

Same molecule, different medicine, the boundary is drawn by dose and intent, not by the drug.

Dose-Defined Risk CategoryTestosterone is a Schedule III controlled substance; performance-enhancement prescribing is off-label/inappropriate

Coordinated 7-Trial Program in Older Men (Snyder et al., NEJM 2016 / JAMA Internal Medicine 2017)

Seven coordinated trials that mapped exactly what testosterone does - and does not - do in older men.

Coordinated RCT Program (Trial Dossier)Independent NIA-funded RCT program (not a drug approval)

Etymology, Steroid Architecture, and the First Therapeutic Use (1930s-40s)

From 'testis + sterol + -one' to propionate injections: how the molecule became a medicine.

Historical / Chemistry & Early TherapyEarly androgen therapy from late 1930s; modern testosterone preparations FDA-approved

Hypo- and hyperthyroidism effects on libido, erection, and ejaculation

Both too much and too little thyroid hormone disturb sexual function - and a simple TSH catches a reversible cause.

Endocrine Sexual DysfunctionNot an FDA product (manifestation of thyroid disease)

How Hypothyroidism and Hyperthyroidism Disrupt Libido, Erections, Ejaculation, and the Sex-Hormone System

An over- or under-active thyroid quietly rewires male sexual function and the entire sex-hormone panel.

Thyroid Endocrine AxisN/A (endogenous hormones); levothyroxine/antithyroid drugs are FDA-approved

Testosterone in Older Men with Mobility Limitations (Basaria et al., NEJM 2010)

The trial stopped early when older, frail men on testosterone had more cardiovascular events.

RCT Halted Early for Safety (Trial Dossier)Investigator-initiated RCT (stopped early)

What Should Happen vs What Often Does, Guideline Standards, Mystery-Shopper Evidence, and the 50x Markup

Built to the standard of a clinical practice guideline, then measured against what the telehealth market actually delivers.

Clinical Monitoring StandardMonitoring is standard of care for FDA-approved testosterone therapy

Hypogonadism in T2D and the T4DM / TIMES2 testosterone-for-diabetes question

Low T in diabetic men is one of medicine's most reproducible associations - but a 40% diabetes reduction did not earn an indication.

Cardiometabolic HypogonadismNot an FDA indication (testosterone is NOT approved to prevent or treat diabetes)

Antares/Halozyme, subcutaneous testosterone auto-injector

Testosterone enanthate in a once-weekly subcutaneous pen.

SubQ Auto-InjectorFDA Approved (Xyosted 2018)

John Ziegler, Methandrostenolone (Ciba, 1958), and the Cold War Birth of Anabolic Steroids in Sport

1958: an American doctor and a Swiss drug company gave sport its first purpose-built oral steroid, and the doping era began.

Historical / Performance-Enhancing DrugsMethandrostenolone withdrawn from US market; Schedule III controlled substance (1990 Anabolic Steroid Control Act)

DHEA, DHEA-S, and Androstenedione, The Adrenal Contribution to Androgen Status

The adrenal gland's androgen contribution, modest in men, and oversold as a testosterone booster.

Adrenal Androgen PathwayDHEA sold as a supplement in the US; androstenedione is a controlled anabolic agent

Overview & the Anabolic:Androgenic Ratio Concept

Synthetic derivatives of testosterone, and the marketing fiction of a 'pure anabolic.'

Androgen Pharmacology (Class Overview)Schedule III (Anabolic Steroids Control Act, 1990; expanded 2004/2014)

Anastrozole and the Off-Label, Contested Practice of Estrogen Suppression

Borrowed from breast-cancer oncology, used to chase a hormone ratio the evidence doesn't endorse.

Aromatase Inhibitor (Off-Label)FDA Approved for breast cancer; off-label in men

Finger-Stick, Dried Blood Spot, and Saliva Assays, Accuracy and Pitfalls

Convenient, increasingly popular, and easy to over-interpret.

Direct-to-Consumer TestingVaries; many DTC tests are lab-developed tests, not FDA-cleared devices

Low Testosterone, BMD, and the TRAVERSE Fracture Paradox

Testosterone builds bone density, yet the biggest trial counted more fractures.

Skeletal Outcome of Androgen Status/TherapyTestosterone is not FDA-approved to prevent fractures or treat osteoporosis; bisphosphonates/anti-resorptives are the approved skeletal therapies

HPA-HPG Crosstalk, Stress, and the Catabolic-Anabolic Balance

The stress hormone that pushes back against testosterone.

Stress-Hormone InteractionNot a product (an endocrine interaction)

Acute-illness suppression versus the contested question of lasting effects

Acute illness reliably lowers testosterone - the hard, honest question is whether COVID leaves a lasting dent.

Acute-Illness HypogonadismNot an FDA product (acute-illness association; testosterone not approved for COVID)

Acute suppression during infection and the recovery question

Testosterone falls in acute COVID, the open question is how fully it returns.

Acute Illness-Related HypogonadismNot a product; an observed effect of SARS-CoV-2 infection

The SERM That Raises Endogenous Testosterone While Preserving Fertility

Raise your own testosterone without shutting the system down, the telehealth alternative to direct TRT.

Selective Estrogen Receptor Modulator (SERM)Not FDA-approved for hypogonadism (use is off-label; the trans-isomer of clomiphene)

The SERM That May Yet Get FDA Attention

A fertility-sparing way to raise a man's own testosterone, that never finished the FDA gauntlet.

Selective Estrogen Receptor Modulator (SERM)Not FDA-approved (Androxal received Complete Response Letters); off-label via compounding

Ovarian Effects, Fertility Preservation, the Incomplete Contraceptive Effect, and Pregnancy-While-on-T

Testosterone stops periods but is NOT birth control, and fertility is often recoverable. Counsel before starting.

Reproductive Health ReferenceOff-label; fertility counseling recommended by WPATH SOC-8 and Endocrine Society

Where Legitimate Medical Masculinization and Wellness-Marketed Testosterone Genuinely Differ

Same molecule, opposite logic: guideline-bounded masculinization versus open-ended 'optimization' marketing.

Comparative / Cultural ReferenceBoth contexts are largely off-label relative to the narrow FDA hypogonadism indication, but differ fundamentally in goals and governance

The Somatotropic Axis and Its Interplay with Androgens

Two anabolic axes that amplify each other, and that the gray market loves to stack.

Endocrine Cross-TalkGH restricted; off-label/anti-aging use is illegal in the US for that indication

Human Chorionic Gonadotropin, Preserving Testicular Function and Fertility on Testosterone

The LH stand-in that keeps the testes working while testosterone shuts the signal off.

LH-Mimetic AdjunctFDA-approved for hypogonadotropic hypogonadism and other indications; fertility-preservation use alongside TRT is off-label

KNDy Neurons, Neurokinin B, Dynorphin, and the GnRH Pulse Generator

The master switch sitting one level above GnRH, the true gatekeeper of the male axis.

Upstream Neuroendocrine ControlInvestigational (research peptide; not approved for low testosterone)

Age-Related Testosterone Decline and the Contested Term 'Andropause'

There is no male equivalent of menopause, and the word that implies otherwise sells testosterone.

Age-Related Endocrine DeclineNot an FDA-recognized indication for TRT

Adipose Signaling, Energy Balance, and the Gonadal Axis

The fat-cell hormone that tells the brain whether there is enough energy to reproduce.

Metabolic-Endocrine LinkNot applicable (physiologic signal)

Evidence on Well-Being and Dysphoria, and the Honest State of the Long-Term Evidence Base

Most studies report improved well-being and reduced dysphoria, drawn largely from observational, shorter-term data.

Psychological Outcomes ReferenceOff-label; outcomes summarized in WPATH SOC-8 evidence reviews

Erythrocytosis, Lipids, Cardiovascular Risk, and Bone Health in Transmasculine Cohorts

The data are largely reassuring on hard cardiovascular endpoints, but long-term, high-quality evidence is still limited. Monitor accordingly.

Safety & Monitoring ReferenceOff-label; monitoring per WPATH SOC-8 and Endocrine Society (Hembree 2017)

Deca-Durabolin (decanoate) / NPP (phenylpropionate); 19-nortestosterone

A genuine medical drug for anemia and wasting, and the origin of 'deca dick.'

19-Nortestosterone (injectable AAS)Schedule III; FDA-approved (US) only for anemia of chronic kidney disease

The Chemistry of Why Oral Steroids Harm the Liver

One small chemical modification makes a steroid oral, and toxic to the liver.

Pharmacology Topic (hepatotoxicity mechanism)Applies to multiple Schedule III oral AAS (e.g., stanozolol, oxymetholone, methandrostenolone, oxandrolone)

Anavar / Oxandrin; 2-oxa DHT-derivative (oral)

The oral with the most genuine medical history, and the most overstated safety reputation.

17a-alkylated oral AAS (DHT-derivative)Formerly FDA-approved (weight gain after trauma/surgery/infection, corticosteroid catabolism, osteoporotic bone pain); US approval withdrawn 2023; Schedule III

Anadrol / Anadrol-50; oral 17aa AAS

A potent anemia drug and one of the most hepatotoxic oral steroids.

Oral 17a-alkylated AAS (DHT-derivative)FDA-approved (Anadrol-50) for anemias of deficient red-cell production; Schedule III

Vaginal/Genital Atrophy, Topical Estrogen, and Cervical/Pelvic Screening on Gender-Affirming T

Testosterone causes real genitourinary atrophy, and retained organs still need screening on a typical schedule.

Pelvic Health ReferenceOff-label; screening per WPATH SOC-8 and standard cancer-screening guidelines applied to retained organs

Chronic Prostatitis / Chronic Pelvic Pain Syndrome (NIH Category III)

The under-recognized, non-infectious cause of pelvic pain, ejaculatory pain, and ED in younger men.

Pelvic Pain SyndromeNot applicable (condition; managed multimodally)

The TOM Trial (Basaria 2010, Halted) and the T-Trials Muscle/Function Data

Real but modest muscle gains, and a trial stopped early for heart events.

Muscle/Function Outcome of Androgen TherapyTestosterone is not FDA-approved for sarcopenia, frailty, or age-related functional decline

Winstrol / Winstrol Depot; oral & injectable 17aa AAS

The drug that ended Ben Johnson's Seoul gold, and a classic example of oral hepatotoxicity.

17a-alkylated AAS (DHT-derivative)Former US approval (hereditary angioedema; vascular disorders); largely discontinued in US; Schedule III

Neurosteroids, Mood, Libido, and Central Androgen Action

Testosterone acts on the brain directly, through estradiol, and through neurosteroid metabolites.

Central Nervous System EffectsNot applicable (physiologic action); TRT not approved as a mood/libido drug

Testopel and Compounded Subcutaneous Implants, The Titration Problem and the BioTE Model

Set-and-forget convenience whose central flaw, you cannot take it back out easily, the marketing rarely mentions.

Subcutaneous Implantable PelletTestopel FDA Approved; compounded pellets not FDA-approved

Informed-Consent Clinics, Telehealth (Plume, FOLX), and a Shifting US Legal Environment

How people actually get care: community informed-consent clinics, telehealth subscriptions, and a fast-changing legal map.

Access & Regulation ReferenceOff-label prescribing; access shaped by state law, payer policy, and clinic model rather than FDA labeling

AndroGel, Direct-to-Consumer 'Low T' Campaigns, and the FDA's 2015 Class Labeling Response, Recent History

How a hormone for diagnosed hypogonadism became a mass-market lifestyle product, then drew an FDA reckoning.

Historical / Pharmaceutical MarketingTestosterone gels FDA-approved for classical hypogonadism; FDA restricted labeling and added warnings in 2015

How Therapeutic Testosterone Shades Into Performance Use

Where monitored replacement ends and unsupervised enhancement begins.

Pharmacology & Public-Health TopicTestosterone is FDA-approved for hypogonadism (Schedule III); supraphysiological/PED use is not

Thyroid Hormone, TSH, and the Male Gonadal Axis

The thyroid quietly sets the dial on how much testosterone is bound versus free.

Endocrine Cross-TalkNot applicable (physiologic relationship)

The testosterone angle of varicocele, distinct from the fertility story

Usually a fertility topic, but it touches testosterone too.

Primary (Testicular) Hypogonadism ContributorVaricocele repair is a surgical/embolization procedure

Where the Evidence Ends and the Salesmanship Begins

A compelling metaphor doing heavy commercial lifting beyond its evidence.

Marketing/Conceptual Frame (Longevity Optimization)Conceptual/marketing frame; 'biological age' tests are largely unregulated wellness products, not FDA-cleared diagnostics

GTx-007, Nonsteroidal SARM

The SARM that tints your vision yellow, a side effect that helped kill its development.

Nonsteroidal Selective Androgen Receptor ModulatorNot FDA approved; did not advance past early development

Equipoise (boldenone undecylenate); veterinary AAS

A horse drug repurposed for physique use, slow, long-detecting, and unstudied in humans.

Testosterone derivative (veterinary AAS)No human approval; approved as a veterinary drug (Schedule III as an anabolic steroid)

The 1889 Testicular-Extract Self-Experiment

A 72-year-old physiologist injected himself, and started a science.

Medical History / BiographyNot Applicable (19th-century experiment)

The Aging Adrenal Androgen Sold as a Hormone-Optimization Staple

An over-the-counter steroid precursor with big promises and thin functional evidence.

Adrenal Androgen Precursor (OTC Supplement)Sold OTC as a dietary supplement in the US (post-DSHEA); not FDA-approved as a drug; banned in sport by WADA

The Precursor Pool: What DHEA and DHEA-S Actually Do (and Don't) in Men

The most abundant steroid in the bloodstream, and one of the most over-promised supplements. A precursor, not a magic bullet.

Adrenal Androgen PrecursorSold as a dietary supplement in the US (not FDA-approved as a drug)

Masteron (drostanolone propionate/enanthate); 2a-methyl-DHT

Once an anti-estrogen breast-cancer drug; now a cosmetic-physique compound.

DHT-derivative (injectable AAS)Historical breast-cancer adjuvant; no current US human approval (Schedule III)

Sermorelin, CJC-1295, Ipamorelin, MK-677, Indirect GH Boosting Marketed to Aging Men

The 'gentler' GH pitch, same axis, same unanswered safety questions.

GH-Releasing Peptides / SecretagoguesNo FDA approval for anti-aging; several are compounded, research-only, or unapproved; MK-677 (ibutamoren) is an unapproved investigational drug

The Rudman 1990 NEJM Study, Its Misuse, and GH-Abuse Risks

One small 1990 paper launched a multibillion-dollar anti-aging myth its own journal later disowned.

Peptide Hormone / Anti-Aging ClaimRecombinant GH approved for specific deficiency states; prescribing GH for anti-aging/athletic enhancement is illegal under US law (FDCA distribution restrictions)

Kisspeptin, Upstream HPG Stimulation for Low Desire

The master switch above the hormone axis, promising in early trials, not a product yet.

Hypothalamic Neuropeptide (Investigational)Not FDA-approved; research-stage

Lesser-known nonsteroidal SARMs (Ligand)

The second-tier SARMs, real preclinical pedigree, zero human trials.

Nonsteroidal Selective Androgen Receptor ModulatorsNot FDA approved; preclinical only

VK5211, Nonsteroidal SARM (Ligand / Viking Therapeutics)

The SARM behind a wave of athlete positives, including from spiked supplements.

Nonsteroidal Selective Androgen Receptor ModulatorNot FDA approved; investigational

The Wellness-to-Medicine Pipeline, TRT + Peptides + GH Secretagogues as a Clinic-Chain Model

Where a lab panel becomes a subscription, and a subscription becomes a stack.

Commercial Care Model (Hormone/Peptide 'Optimization')Business model, not a regulated product; bundles FDA-approved TRT with off-label, compounded, or research-only agents

Proviron; oral DHT-derivative (1-methyl-DHT)

An oral DHT-derivative used more as an SHBG and estrogen tool than for muscle.

Oral DHT-derivative (non-17aa androgen)Not US-approved; marketed abroad for androgen deficiency/some male infertility contexts; Schedule III in US

Dianabol / Dbol (metandienone, methandienone); oral 17aa AAS

The original performance steroid, born from the Cold War of weightlifting.

Oral 17a-alkylated AASFormer US approval long withdrawn; Ciba ceased production; Schedule III

Primobolan (enanthate, injectable) / Primobolan Depot; methenolone acetate (oral)

The 'mild' DHT-derivative with an outsized reputation and a heavily counterfeited supply.

DHT-derivative (AAS, injectable & oral non-17aa)No current US approval; available/approved in some countries historically for wasting/anemia (Schedule III in US)

MK-0677, Oral growth hormone secretagogue (NOT a SARM)

Sold with SARMs, but it is a GH secretagogue, and it raises blood sugar and causes edema.

Growth Hormone Secretagogue / Ghrelin Receptor Agonist (not a SARM)Not FDA approved; multiple Phase II trials, never submitted for approval

Enobosarm / GTx-024 / S-22, Nonsteroidal SARM

The most-studied SARM, and a case study in why 'lean mass' is not the same as approval.

Nonsteroidal Selective Androgen Receptor ModulatorNot FDA approved; investigational (multiple failed and ongoing trials)

Restarting the HPG Axis After Androgen Suppression

An unapproved practice meant to undo self-inflicted suppression.

Off-Label Axis-Recovery RegimenNo FDA-approved PCT protocol (off-label use of various drugs)

The Concept, the Claims, and the Medical Reality

The forum ritual meant to 'restart' the body, and why suppression is sometimes permanent.

Pharmacology Topic (endocrine recovery)PCT drugs (e.g., clomiphene, tamoxifen, hCG) are used off-label for this; 'PCT' itself is not an FDA-approved regimen

The Mother Steroid, Steroidogenesis, and the 'Precursor' Marketing Myth

The first steroid downstream of cholesterol, but supplementing it does not reliably flow into testosterone.

Steroid Precursor / SupplementSold as a dietary supplement in the US; not approved to raise testosterone

Organizational vs Activational Effects, and the Contested 2D:4D Digit-Ratio Literature

What fetal testosterone may organize, and why one popular proxy is weak.

Developmental NeuroendocrinologyNot applicable (developmental neuroscience)

Nonsteroidal SARM (Radius Health / Ellipses)

Marketed as the strongest SARM, and linked to multiple published cases of severe liver injury.

Nonsteroidal Selective Androgen Receptor ModulatorNot FDA approved; investigational (breast cancer)

Nonsteroidal SARM, the 'most suppressive'

Studied as a male contraceptive in rats, because it shuts down fertility completely.

Nonsteroidal Selective Androgen Receptor ModulatorNot FDA approved; preclinical only (no human trials)

Mislabeling, the SARMs Control Act, FDA/FTC enforcement, and why none are approved

The honest bottom line: no SARM is approved, the bottles rarely match their labels, and the law is closing in.

Regulatory & Safety Synthesis MonographNo SARM is FDA approved for human use; all are unapproved new drugs

Selective Androgen Receptor Modulators (Ostarine, Ligandrol, RAD-140, etc.)

Marketed as safer steroids - sold illegally, none FDA approved.

Investigational Androgen Receptor ModulatorNot FDA approved; investigational, illegal in supplements

Manopause, the Abbott 'Is It Low T?' Campaign, and the FDA 2015 Class-Labeling Response

How a normal feature of aging was rebranded as a treatable deficiency disease.

Disease-Awareness / Direct-to-Consumer Marketing ConstructFDA 2015 class-wide labeling change restricted approved use to hypogonadism from specified medical conditions and required a cardiovascular warning

Trenbolone acetate / enanthate; (Finaplix, Parabolan historically)

A cattle-growth implant with no approved human use, and one of the most harm-associated AAS.

19-Nortestosterone (veterinary-origin AAS)No human medical approval; veterinary cattle-implant origin (Schedule III as an anabolic steroid)

Steroidal AR partial agonist marketed as a 'myostatin-inhibitor SARM'

Marketed as a myostatin-crushing SARM, but it is a synthetic steroid with no human data.

Steroidal AR Partial Agonist (mislabeled 'SARM')Not FDA approved; no human trials

Charles-Edouard Brown-Sequard's 1889 Testicular-Extract Self-Injections, Organotherapy's Birth and Its Long Placebo Shadow

1889: a 72-year-old physiologist injected himself with crushed dog and guinea-pig testes, and launched a placebo industry.

Historical / OrganotherapyNot Applicable (1889 self-experiment)

GW1516, PPAR-delta agonist (NOT a SARM)

Sold alongside SARMs, but it is not one, and GSK killed it because it caused cancer in animals.

PPAR-delta Agonist (misclassified as a SARM)Not FDA approved; development terminated by GSK (2007) over carcinogenicity

Early-Stage Science, Honestly Framed

A genuinely futuristic idea, and, today, almost entirely preclinical.

Experimental Gene/Cell TherapyNo approved gene therapy for hypogonadism; preclinical/early research only

REV-ERB agonist (NOT a SARM)

'Exercise in a pill', except its oral bioavailability is essentially zero.

REV-ERB Agonist (misclassified as a SARM)Not FDA approved; tool compound only

Eugen Steinach and the 1920s 'Steinach Operation', Vasectomy as Rejuvenation Surgery

The Viennese physiologist who convinced a generation that tying off the vas deferens could turn back the clock.

Historical / Rejuvenation SurgeryNot Applicable (discredited 1920s procedure)

Serge Voronoff and the 1920s Testicular Xenotransplant Craze

When wealthy men paid surgeons to graft monkey testicle into their own.

Medical History / BiographyNot Applicable (discredited 1920s procedure)

Serge Voronoff's 1920s Xenograft Testicle Transplants, The Anatomy of a Medical Mania

The 1920s surgeon who grafted slivers of chimpanzee testicle into wealthy men, and was world-famous before he was discredited.

Historical / Rejuvenation SurgeryNot Applicable (discredited 1920s procedure)